Navigation Links
EpiCept Reports Second Quarter 2013 Operating and Financial Results
Date:7/31/2013

i>Cost of goods sold in the second quarter of 2013 and 2012 was zero and $0.4 million, respectively, consisting solely of the cost for Ceplene® inventory sold during the quarter. 

Selling, General and Administrative (SG&A) ExpenseSG&A expense in the second quarter of 2013 decreased by 36%, or $0.5 million, to $0.9 million from $1.4 million in the second quarter of 2012.  The decrease was primarily attributable to lower salary and salary related expenses as the result of a reduction in staff and lower consulting expenses.  SG&A expense in the six months ended June 30, 2013 decreased by 39%, or $1.1 million, to $1.7 million from $2.8 million in the six months ended June 30, 2012.  The decrease was primarily attributable to lower salary and salary related expenses as the result of a reduction in staff and lower consulting expenses.  The Company expects general and administrative expenses to remain at approximately current levels through the close of the merger with Immune.

Research and Development (R&D) Expense R&D expense in the second quarter of 2013 decreased by 30%, or $0.3 million, to $0.7 million from $1.0 million in the second quarter of 2012.  This decrease was primarily related to lower clinical trial expenses in connection with the sale of EpiCept's rights to Ceplene® in Europe and certain Pacific Rim countries in June 2012.  R&D expense in the six months ended June 30, 2013 decreased by 57%, or $1.3 million, to $1.0 million from $2.3 million in the six months ended June 30, 2012.  This decrease was primarily related to lower clinical trial expenses in connection with the sale of EpiCept's rights to Ceplene® in Europe and certain Pacific Rim countries in June 2012 and lower salary and salary related expenses as the result of a reduction in staff.  The Company expects R&D expense to remain at approximately curren
'/>"/>

SOURCE EpiCept Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
2. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
3. Interleukin Genetics Reports Third Quarter 2011 Financial Results
4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
5. Nile Therapeutics Reports 2011 Third Quarter Financial Results
6. Pharmasset Reports Fiscal Year End 2011 Financial Results
7. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
8. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
9. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
10. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
11. Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014 An analysis ... structures of all Dengue virus strains in Pubmed, has ... back to 1944. This conservation and sharing of specific ... Synthetic Dengue Blocker-Vaccine™ candidate, as it did for the ... both of which have been found to be effective ...
(Date:8/26/2014)... , Aug. 26, 2014   Lycera Corp ... breakthrough oral medicines to treat autoimmune disease and ... today announced the appointment of Harinder Singh ... advisory board.  Dr. Singh will lead the board,s ... Lycera,s multiple ongoing research programs and pipeline of ...
(Date:8/26/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 Genedata, ... drug discovery and life science research, today announced ... will be held in Asia, Europe, and ... global pharmaceutical companies and leading research organizations will ... best practices, case studies, and upcoming challenges in ...
Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3
... Sept. 20 HelixLife™ recently launched the following ... (Vitamins & Skin Serum), Anti-Acne Skin Serum, Foundational ... lines were developed in partnership with GeneLink BioSciences, ... personal health and skin care using GeneLink,s advanced ...
... Sept. 20 Epitomics, Inc. today announced that The ... chosen the company to distribute a panel of LRRK2 ... the two parties. Under a special arrangement the antibodies ... PD research community to help advance LRRK2 therapeutic development ...
... a central alternative to petroleum-based energy production. However, current ... yield and is more expensive to mass-produce. In addition, ... on the environment is incomplete, experts say. To ... of solar power, a research team from Rochester Institute ...
Cached Biology Technology:HelixLife Launches Custom Health Supplements, Anti-Aging and Acne Skin Serums 2Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation 2Research team assesses environmental impact of organic solar cells 2
(Date:8/26/2014)... , August 26, 2014 ... von Oxygen Forensic Passware Analyst bekannt, einem ... preisgekrönten Erfassungs- und Analysetools von Oxygen mit ...     Das neue Tool kombinierte ... einem einzigen nahtlosen Ablauf. Das neu hinzugekommene ...
(Date:8/25/2014)... of the first U.S. outbreaks of the H1N1 virus ... 2,000 people. A university math and biology professor has ... to gain insight into how only a few infected ... university community., The fall 2009 semester hadn,t even started ... Health and Wellness Services clinic11 one day, and just ...
(Date:8/25/2014)... University of California, San Diego School of Medicine have found ... the primary form of a deadly brain cancer are ... DNA sequence of the tumor, but in its epigenetic signature. ... in the journal Oncotarget . , "There is ... DNA of the cancer cell," said Clark Chen, MD, PhD, ...
Breaking Biology News(10 mins):Oxygen Forensic Passware Analyst erfasst geschützte Mobilgerätedaten 2WSU flu outbreak provides rare study material 2WSU flu outbreak provides rare study material 3Finding keys to glioblastoma therapeutic resistance 2
... why Starbucks puts boxes of breath mints close to the ... in your mouth, strong enough to startle your co-workers too. ... by renowned breath specialist Prof. Mel Rosenberg of TAU,s Sackler ... the bacteria that lead to bad breath. New laboratory tests ...
... in German . , Mitochondria are ... harbor an elaborately folded inner membrane. It holds a ... cavities (cristae). The narrow shape of the entrance or ... the intracristal space and storage of molecules. Cytochrome c, ...
... and Wilfrid Laurier University today announce the launch ... a visible point of open access archiving of ... community. Built on BioMed Central,s "Open ... access knowledge and technology experience, Laurier IR is ...
Cached Biology News:A breath mint made from... coffee? 2How mitochondria get their membranes bent 2'Canadian excellence' strengthened by extensive adoption of open access 2
Recombinant Rhesus Monkey IFN Alpha Activity: 2.9 x 10 8 u/mg...
... space and organize gloves, safety glasses, ... are the perfect benchtop storage bins ... processing and manufacturing. Clear static-dissipative PVC ... they attract. Many other sizes and ...
... Ultrapure C 25 H 27 N 2 ... PRODUCT SPECIFICATIONS Form: Dark burgundy metallic powder Identity: ... 2 O, 1 cm): greater than or equal ... Drying: less than or equal to 10.0% lambda ...
...
Biology Products: